Establishing reference values for both total soluble Fms-like tyrosine kinase 1 and free placental growth factor in pregnant women

Hypertension Research

Volumn 28, Issue 9, 2005, Pages 727-732

  Hirashima, Chikako ^a   Ohkuchi, Akihide ^a   Arai, Fujimi ^a   Takahashi, Kayo ^a   Suzuki, Hirotada ^a   Watanabe, Takashi ^a   Kario, Kazuomi ^a   Matsubara, Shigeki ^a   Suzuki, Mitsuaki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Placental growth factor; Preeclampsia; Pregnancy; Reference values; Soluble fms like tyrosine kinase 1

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PREECLAMPSIA; PREGNANCY; PROTEIN BLOOD LEVEL; REFERENCE VALUE; STATISTICAL ANALYSIS;

ADULT; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LONGITUDINAL STUDIES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; REFERENCE VALUES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 28444460382     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.28.727     Document Type: Article

References (18)

1. Yum MK, Kim K, Kim JH, Park EY: A consistent abnormality in the average local smoothness of fetal heart rate in growth-restricted fetuses affected by severe pre-eclampsia. Hypertens Res 2004; 27: 911-918.
2. Maruyama A, Nakayama T, Sato N, Mizutani Y, Furuya K, Yamamoto T: Association study using single nucleotide polymorphisms in the estrogen receptor beta (ESR2) gene for preeclampsia. Hypertens Res 2004; 27: 903-909.
3. Campbell S: Parallel universes. Ultrasound Obstet Gynecol 2004; 24: 701-703.
4. Khong TY, De Wolf F, Robertson WB, Brosens I: Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049-1059.
5. Lin S, Shimizu I, Suehara N, Nakayama M, Aono T: Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995; 85: 760-765.
6. Maynard SE, Min JY, Merchan J, et al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658.
7. Levine RJ, Maynard SE, Qian C, et al: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683.
8. Ikeda Y, Fukuda N, Wada M, et al: Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens Res 2004; 27: 119-128.
9. Imanishi T, Hano T, Nishio I: Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res 2004; 27: 101-108.
10. Uruno A, Sugawara A, Kanatsuka H, et al: Hepatocyte growth factor stimulates nitric oxide production through endothelial nitric oxide synthase activation by the phosphoinositide 3-kinase/Akt pathway and possibly by mitogen-activated protein kinase kinase in vascular endothelial cells. Hypertens Res 2004; 27: 887-895.
11. Sata M, Hirata Y, Nagai R: Role of Fas/Fas ligand interaction in ischemia-induced collateral vessel growth. Hypertens Res 2002; 25: 577-582.
12. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ: Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998; 179: 1539-1544.
13. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177-182.
14. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS: Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001; 184: 1267-1272.
15. Chappell LC, Seed PT, Briley A, et al: A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127-136.
16. Livingston JC, Haddad B, Gorski LA, et al: Placenta growth factor is not an early marker for the development of severe preeclampsia. Am J Obstet Gynecol 2001; 184: 1218-1220.
17. Thadhani R, Mutter WP, Wolf M, et al: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770-775.
18. Stepan H, Geide A, Faber R: Soluble fms-like tyrosine kinase 1. N Engl J Med 2004; 351: 2241-2242.